Jew OS, Liu WW, Stamey C, Kheterpal M, et al. De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy. J Am Acad Dermatol 2024 Jun 4:S0190-9622(24)00831.
PMID: 38844009